Validation of the Individualized Metabolic Surgery score in predicting long‐term remission of diabetes after duodenal switch‐type procedures
Authors' conclusion
The IMS score properly classifies the severity of T2D in our study cohort and adequately predicts its long-term remission after DS-type procedures. While T2D remission decreases with more severe IMS scores, long-term remission remains high after DS-type procedures among patients with severe disease.
Study context
- Population
- Patients with T2D and severe obesity who underwent duodenal switch (DS)-type procedures at a single institution, December 2010 to December 2018complete long-term glycaemic data
- Participants
- 30 patients
- Outcome
- Validation of the IMS score (AUC) and long-term remission of T2D, especially in severe disease
- Follow-up
- ≥ 5 years
Methodological detailssingle cohort, single institution
- Single cohort
- Single institution
Main finding
As reported in the abstract
Accuracy of the IMS score in predicting long-term (≥ 5 years) T2D remission
Individualized Metabolic Surgery (IMS) scores predicted long-term T2D remission, AUC
0.77
Observational data: associations, not effects.
Further findings
Long-term T2D remission in IMS-based severe diabetes: DS-type procedures vs gastric bypass and/or SG from original IMS study · ≥ 5 years · higher with DS-type procedures
P < 0.05
Original publication
Validation of the Individualized Metabolic Surgery score in predicting long‐term remission of diabetes after duodenal switch‐type procedures. Diabetes Obes Metab. Published 9 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →